Personal Care

Johnson & Johnson

$162.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.40 (-0.25%) Today
+$0.32 (+0.20%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell JNJ and other stocks, options, and ETFs commission-free!

About JNJ

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. The listed name for JNJ is Johnson & Johnson.

CEO
Alex Gorsky
Employees
132,200
Headquarters
New Brunswick, New Jersey
Founded
1887
Market Cap
427.47B
Price-Earnings Ratio
25.19
Dividend Yield
2.48
Average Volume
9.29M
High Today
$164.14
Low Today
$161.81
Open Price
$163.17
Volume
6.84M
52 Week High
$164.14
52 Week Low
$109.16

Collections

JNJ News

ReutersJan 18

South Africa to get 9 million J&J vaccine shots - ministry

JOHANNESBURG (Reuters) - South Africa, which has yet to receive its first coronavirus vaccine doses, will be getting 9 million from Johnson & Johnson, the healt
ReutersJan 15

Progress reported on one-dose J&J vaccine; COVID-19 reinfections seen as rare

(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-1
MarketWatchJan 14

Boeing, Johnson & Johnson share gains contribute to Dow's 150-point climb

Shares of Boeing and Johnson & Johnson are trading higher Thursday morning, propelling the Dow Jones Industrial Average into positive territory. The Dow DJIA, +

JNJ Earnings

$0.00
$0.86
$1.72
$2.58
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Jan 26, Pre-Market

You May Also Like

JKD

More JNJ News

MarketWatchJan 14

J&J's COVID-19 vaccine candidate shows it generates antibodies in early-stage trial

Shares of Johnson & Johnson JNJ, -0.15% gained 1.7% in premarket trading on Thursday, the day after a study published in the New England Journal of Medicine sho
TIMEJan 14

Johnson & Johnson’s 1-Shot COVID-19 Vaccine Shows Promise in Early-Stage Trials

Johnson & Johnson’s experimental one-shot Covid-19 vaccine generated a long-lasting immune response in an early safety study, providing a glimpse at how it will
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure